Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett’s esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies
Christopher J. Lewis(Salford Royal Hospital), Stephen E. Attwood(Durham University), Gordon Armstrong(Salford Royal Hospital), Susan Pritchard, Sri G. Thrumurthy(Lancashire Teaching Hospitals NHS Foundation Trust)
Cited by 14
Related Papers
Esophageal eosinophilia with dysphagia
|Digestive Diseases and Sciences|1993|889
Cyclooxygenase-2 Expression in The Barrettʼs Metaplasia–Dysplasia–Adenocarcinoma Sequence
|The American Journal of Gastroenterology|2001|246
Surgical Therapy in Barrettʼs Esophagus
|Annals of Surgery|1990|230